Strip of 15 Units
Old MRP ₹118.5
MRP ₹111.09
₹92.2
₹7.41/Units
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionDapagain M 10mg/500mg Tablet 15 is used to manage type 2 diabetes. It combines Dapagliflozin (SGLT2 inhibitor) and Metformin (biguanide). This dual action works by increasing glucose excretion through urine and improving insulin sensitivity. It is also used to reduce the risk of hospitalization due to heart failure in adults with type 2 diabetes and established cardiovascular risk factors.
Dapagain M 10mg/500mg Tablet 15 is used for the management of type 2 diabetes mellitus in adults when diet and exercise alone fail to provide adequate blood sugar control. It is also prescribed to reduce the risk of hospitalisation for heart failure in adults with type 2 diabetes and established heart disease or multiple heart disease risk factors.
Here are some instructions to follow while taking Dapagain M 10mg/500mg Tablet 15:
Take the medicine as prescribed by your doctor.
Swallow the tablet whole with a glass of water. Do not crush, cut, or chew it.
If you have any questions about how to take this medicine, consult your doctor.
Dapagain M 10mg/500mg Tablet 15 is taken orally.
Dapagain M 10mg/500mg Tablet 15 may result in a few common side effects: dehydration, genital mycotic infections, urinary tract infections, and low blood pressure.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Dapagain M 10mg/500mg Tablet 15. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Genital mycotic infections: Maintain good genital hygiene to lessen this effect.
Urinary tract infections: Stay hydrated to help manage this side effect.
Dapagain M 10mg/500mg Tablet 15 consists of two active ingredients:
Dapagliflozin (10 mg): As an SGLT2 inhibitor, dapagliflozin minimises kidney glucose reabsorption and lowers the renal threshold for glucose. This action increases glucose excretion through urine, thereby decreasing blood glucose levels.
Metformin (500 mg): Metformin reduces liver glucose production and intestinal absorption of glucose while improving insulin sensitivity by boosting peripheral glucose uptake and utilisation. These actions collectively help lower blood glucose levels.
Consult your doctor before taking Dapagain M 10mg/500mg Tablet 15 if you are pregnant. It is essential to discuss the potential risks and benefits with your doctor.
Dapagain M 10mg/500mg Tablet 15 is not recommended for breastfeeding women. Consult your doctor to understand the possible risks and benefits.
Caution is advised when consuming alcohol while taking this medicine. Alcohol may interact with Dapagain M 10mg/500mg Tablet 15, potentially leading to an increased risk of lactic acidosis and hypoglycemia.
If you have liver health issues, it is important to discuss them with your doctor before starting Dapagain M 10mg/500mg Tablet 15. This medicine may impact liver function, so caution is recommended.
Dapagain M 10mg/500mg Tablet 15 is not suitable if you have severe kidney impairment. For those with moderate renal impairment, it's advisable to consult your doctor before starting this medicine.
No specific precautions are required while driving or operating machinery after taking Dapagain M 10mg/500mg Tablet 15. However, if you experience side effects like dizziness, avoid such activities until you feel well again.
Avoid using this medicine if you're allergic to dapagliflozin, metformin, or any other ingredient in Dapagain M 10mg/500mg Tablet 15. If unsure, consult your doctor.
This medicine is not recommended for use in children under 18 years of age. Always consult a doctor before giving any medicine to a child.
Older patients should take Dapagain M 10mg/500mg Tablet 15 under medical supervision as they may be more susceptible to its side effects. Caution is advised if patients are above 70 years of age due to potential liver and kidney issues. Your doctor will guide you based on your health status.
Dapagain M 10mg/500mg Tablet 15 interacts with the following medicines:
Diuretics: This medication may interact with diuretics like furosemide or hydrochlorothiazide, potentially increasing the risk of hypotension and electrolyte imbalances.
Insulin and insulin secretagogues: Concomitant use of insulin or insulin secretagogues such as glipizide with Dapagain M 10mg/500mg Tablet 15 may increase the risk of hypoglycemia.
Carbonic anhydrase inhibitors: Medicines like acetazolamide may interact with this medication, possibly increasing the risk of lactic acidosis.
Cationic medicines: Medications such as amiloride and digoxin may reduce metformin elimination, leading to increased metformin levels in your body.
There are no specific food interactions known with Dapagain M 10mg/500mg Tablet 15.
Dapagain M 10mg/500mg Tablet 15 interacts with the following diseases:
Renal impairment: Patients with renal impairment should exercise caution as this medicine could exacerbate their condition.
Heart failure: This medication could impact heart function, making it crucial to monitor heart health closely when on this medication.
Pancreatitis: Patients with a history of pancreatitis might experience worsening of their condition due to this medicine.
You should take your daily dose of Dapagain M 10mg/500mg Tablet 15 as directed by your doctor. The dosage might be adjusted depending on factors like the severity of your condition and how you respond to the medicine. Always stick to the prescribed dosage and never exceed it without consulting your doctor.
Overdosing on Dapagain M 10mg/500mg Tablet 15 may lead to side effects like lightheadedness or dizziness. If you take more than the prescribed dose and experience such symptoms, consult your doctor.
If you forget to take your Dapagain M 10mg/500mg Tablet 15, take it as soon as you remember. However, if it's nearly time for your next dose, skip the missed one and continue with your regular schedule. Never adjust your dosage without asking your doctor first.
Store Dapagain M 10mg/500mg Tablet 15 at room temperature, ideally between 20°C and 25°C.
Keep it in its original packaging to protect it from light and moisture.
Place the medicine in a secure location, away from children's reach.
Maintain a balanced diet low in sugar, as Dapagain M 10mg/500mg Tablet 15 is used to manage type 2 diabetes. This includes limiting the intake of sweets, fizzy drinks, and food high in carbohydrates.
Regular exercise is crucial. Incorporate physical activities like brisk walking or cycling into your daily routine to help lower blood glucose levels and boost the effectiveness of Dapagain M 10mg/500mg Tablet 15.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Type 2 diabetes, Cardiovascular disease |
| Drug Category | SGLT2 inhibitor, Biguanide |
| Therapeutic Category | Antidiabetic |
No, Dapagain M 10mg/500mg Tablet 15 is specifically designed to manage type 2 diabetes in adults.
Yes, you should check your kidney function before starting and during treatment, as dose adjustments might be needed if you have moderate kidney impairment.
No, the tablet should be swallowed whole without crushing or chewing it to ensure proper release of the active ingredients.
If you have symptoms like a burning sensation during urination or cloudy urine, please consult your doctor promptly for evaluation and appropriate management.
Caution is advised while using this medicine during pregnancy. Inform your doctor about your pregnancy before starting the medicine.
Yes, regular monitoring of vitamin B12 levels is recommended, especially if you have risk factors for deficiency.
Yes, it can be used alone or with other antidiabetic medicines; however, always consult your doctor about any potential medicine interactions.
Check out Editorial Policy
Dapagliflozin: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB06292
Dapagliflozin: MedlinePlus Drug information. (n.d.). https://medlineplus.gov/druginfo/meds/a614015.html
National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 9887712, Dapagliflozin. Retrieved June 18, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/Dapagliflozin
Metformin: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB00331
Metformin: MedlinePlus drug information. (n.d.). https://medlineplus.gov/druginfo/meds/a696005.html
National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 4091, Metformin. Retrieved June 18, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/Metformin.
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
13399 users bought this instead
Read More
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaAll MedicinesAll BrandsNeed HelpFAQSecuritySubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.9.0
2025 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
